Dr Reddys Laboratories (RDY) Common Equity (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Common Equity of $4.08 billion for the quarter ended Jun 30, 2026, down 1.2% from $4.13 billion a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Common Equity (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Common Equity came in at $4.05 billion, up 2.7% from the prior year.
- Annual Common Equity has increased for eight consecutive years, with a five-year compound annual growth rate of 11.4% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Common Equity was $3.95 billion in the year ended Mar 31, 2025 (+17.3%), $3.37 billion in the year ended Mar 31, 2024 (+19.6%), $2.82 billion in the year ended Mar 31, 2023 (+12.1%) and $2.51 billion in the year ended Mar 31, 2022 (+6.1%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Common Equity since the quarter ended Mar 31, 2025.
- On a year-over-year basis, Common Equity increased in seven of the last eight quarters, with growth averaging 12.5%.
- The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Jun 30, 2023, with growth of 22.4%; the weakest was the quarter ended Jun 30, 2026, with a decline of 1.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $4.16 billion (quarter ended Mar 31, 2026), $4.22 billion (quarter ended Dec 31, 2025) and $4.15 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 4.08 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08 Bn |
| Mar 31, 2026 | 4.16 Bn |
| Dec 31, 2025 | 4.22 Bn |
| Sep 30, 2025 | 4.15 Bn |
| Jun 30, 2025 | 4.13 Bn |
| Mar 31, 2025 | 3.89 Bn |
| Dec 31, 2024 | 3.81 Bn |
| Sep 30, 2024 | 3.69 Bn |
| Jun 30, 2024 | 3.53 Bn |
| Mar 31, 2024 | 3.38 Bn |
| Dec 31, 2023 | 3.22 Bn |
| Sep 30, 2023 | 3.06 Bn |
| Jun 30, 2023 | 2.99 Bn |
| Mar 31, 2023 | 2.81 Bn |
| Dec 31, 2022 | 2.68 Bn |
| Sep 30, 2022 | 2.59 Bn |
| Jun 30, 2022 | 2.44 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Dec 31, 2021 | 2.54 Bn |
| Sep 30, 2021 | 2.48 Bn |
API Access
Dr Reddys Laboratories Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();